Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELL
4276
DELISTED
PhenomeX Inc. Common Stock
CELL
| $51.1K | ﹤0.01% |
44,018
+19,301
| +78% | +$35.3K |
|
|
NOTV
4277
DELISTED
Inotiv
NOTV
| $51K | ﹤0.01% |
11,785
+7,109
| +152% | +$45.3K |
|
|
GMVD
4278
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
| $51K | ﹤0.01% |
+56,001
| New | +$161K |
|
4279
US Global Investors
GROW
$35.5M
| $51K | ﹤0.01% |
19,083
| – | – |
|
|
CAMP
4280
DELISTED
CalAmp Corp.
CAMP
| $50.9K | ﹤0.01% |
+616
| New | +$60.2K |
|
4281
Immuneering
IMRX
$267M
| $50.7K | ﹤0.01% |
5,217
-1,541
| -23% | -$8.75K |
|
4282
Bakkt Inc
BKKT
$321M
| $50.6K | ﹤0.01% |
1,177
+494
| +72% | +$19.2K |
|
|
PVBC
4283
DELISTED
Provident Bancorp
PVBC
| $50.2K | ﹤0.01% |
7,334
-7,608
| -51% | -$63.1K |
|
|
SBT
4284
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $50.1K | ﹤0.01% |
8,846
+4,193
| +90% | +$25.1K |
|
4285
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
| $50K | ﹤0.01% |
+2,048
| New | +$49.6K |
|
|
OMIC
4286
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $49.7K | ﹤0.01% |
1,369
+454
| +50% | +$27.8K |
|
|
TCRR
4287
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $49.7K | ﹤0.01% |
33,116
| – | – |
|
4288
Consumer Portfolio Services
CPSS
$202M
| $49.6K | ﹤0.01% |
4,640
+2,080
| +81% | +$21.2K |
|
4289
Suburban Propane Partners
SPH
$1.24B
| $49.5K | ﹤0.01% |
3,233
-8,085
| -71% | -$125K |
|
|
SY
4290
So-Young International
SY
$185M
| $49.5K | ﹤0.01% |
23,036
-787,681
| -97% | -$1.82M |
|
4291
PUT
Kroger
KR
$35.4B
| $49.4K | ﹤0.01% |
1,000
-1,000
| -50% | -$45.7K |
|
|
VXRT
4292
DELISTED
Vaxart
VXRT
| $49.1K | ﹤0.01% |
64,889
+30,364
| +88% | +$28.2K |
|
4293
First Guaranty Bancshares
FGBI
$159M
| $49K | ﹤0.01% |
3,129
+1,500
| +92% | +$30.6K |
|
|
ML
4294
DELISTED
MoneyLion Inc.
ML
| $49K | ﹤0.01% |
2,875
+1,183
| +70% | +$24.6K |
|
4295
Novartis
NVS
$297B
| $48.9K | ﹤0.01% |
532
-707
| -57% | -$61.7K |
|
4296
FTC Solar
FTCI
$44M
| $48.8K | ﹤0.01% |
2,170
+1,018
| +88% | +$27.1K |
|
4297
Imperial Petroleum
IMPP
$213M
| $48.7K | ﹤0.01% |
16,771
| – | – |
|
4298
Shattuck Labs
STTK
$675M
| $48.4K | ﹤0.01% |
16,471
| – | – |
|
|
BURU
4299
DELISTED
NUBURU INC
BURU
| $48.1K | ﹤0.01% |
+90
| New | +$113K |
|
4300
Culp Inc
CULP
$44.1M
| $48K | ﹤0.01% |
9,228
| – | – |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.